Fujita Health University releases a preliminary report of Favipiravir Observational Study

Favipiravir Observational Study Group (principal investigator: Dr. Yohei Doi, Fujita Health University) released a preliminary report of the Favipiravir Observational Study in Japan on the Japanese Association for Infectious Diseases website. URL: //www.kansensho.or.jp/uploads/files/topics/2019ncov/covid19_casereport_en_200529.pdf Favipiraivr (brand name Avigan) is an anti-influenza drug which was developed by FUJIFILM Toyama Chemical Co., Ltd. Favipiravir can be administered to…

UM School of Medicine’s Institute of Human Virology awarded grants for COVID-19

The Center for International Health, Education and Biosecurity (Ciheb) at the University of Maryland School of Medicine’s Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention (CDC) to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique. “Low-resource regions in Africa are vulnerable…